FDA Approved: ODOMZO — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sun Pharmaceutical's ODOMZO (sonidegib) submitted by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Odomzo (sonidegib)

Snippet

SUPPL AP for ODOMZO (SONIDEGIB)